Search & Filter

Welsh mental health charity Gofal has published a report about primary mental health services in Wales that shows no improvement in patient outcomes since the implementation of the Mental Health (Wales) Measure in 2012.

A new treatment for adults with iron deficiency anaemia and inflammatory bowel disease, who have previously failed on oral iron (ferrous) products, has been launched in the UK.

Of all British National Formulary (BNF) drug categories, the prescriptions to rise the most in 2015 were antidepressants, new figures by the Health and Social Care Information Centre (HSCIC) have revealed.

For the first time in the UK, more than 10,000 people aged 55 and over were diagnosed with malignant melanoma - the most dangerous form of skin cancer - in a single year, according to the latest figures released by Cancer Research UK

The All Wales Medicines Strategy Group (AWMSG) has recommended Trulicity (dulaglutide once weekly injection) for adults with type 2 diabetes mellitus, pharma Eli Lilly has announced.

The All Wales Medicines Strategy Group (AWMSG) has recommended Trulicity (dulaglutide once weekly injection) for adults with type 2 diabetes mellitus, pharma Eli Lilly has announced.

A new national clinical guideline for Scotland has been published, which makes recommendations for effective assessment, diagnosis and interventions for autism spectrum disorders (ASD). The guideline's recommendations reflect the growing body of evidence that ASD affects boys and girls equally, and can present across all ages.

When considering admitting patients over the age of 65 for acute hospital care, alternatives such as hospital-at-home, admission to a local community hospital or extended stays and treatment in A&E are a viable option say NIHR-funded researchers from the University of Bristol and the University for the West of England (UWE Bristol).

A new fixed-combination foam spray for the treatment of plaque psoriasis has been launched by Leo Pharma. The cutaneous foam spray is the first of its type to be available in the UK.

Researchers at consultants GlobalData believe the UK's decision to leave the EU could have major consequences for the country's pharmaceutical and medical device sectors, it has announced.

The European Medicines Agency (EMA) has granted marketing approval of the mylife YpsoPump insulin pump for use with prefilled pump cartridge NovoRapid PumpCart, Novo Nordisk and Ypsomed have announced.

More than a third of elderly patients who are dying receive "invasive and potentially harmful" treatments in their last weeks of life, according to a review, led by experts at the University of New South Wales in Australia.

Almost a third of older men in England who have long-term health problems are lonely, according to an analysis by Age UK. 

The first fixed-combination, cutaneous foam spray for the once-daily topical treatment of all extents of plaque psoriasis for patients who are 18 years or older has been launched in the UK.

The Royal College of Nursing (RCN) has today issued a stark warning about pressures on A&E services, saying high demand and major incidents have become commonplace throughout the year.